[go: up one dir, main page]

FR2852841B1 - Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement - Google Patents

Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement

Info

Publication number
FR2852841B1
FR2852841B1 FR0303886A FR0303886A FR2852841B1 FR 2852841 B1 FR2852841 B1 FR 2852841B1 FR 0303886 A FR0303886 A FR 0303886A FR 0303886 A FR0303886 A FR 0303886A FR 2852841 B1 FR2852841 B1 FR 2852841B1
Authority
FR
France
Prior art keywords
cosmetic
treatment
methods
amino acids
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0303886A
Other languages
English (en)
Other versions
FR2852841A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0303886A priority Critical patent/FR2852841B1/fr
Priority to PCT/FR2004/000769 priority patent/WO2004087091A2/fr
Priority to EP04742373A priority patent/EP1620185A2/fr
Publication of FR2852841A1 publication Critical patent/FR2852841A1/fr
Application granted granted Critical
Publication of FR2852841B1 publication Critical patent/FR2852841B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0303886A 2003-03-28 2003-03-28 Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement Expired - Fee Related FR2852841B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0303886A FR2852841B1 (fr) 2003-03-28 2003-03-28 Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement
PCT/FR2004/000769 WO2004087091A2 (fr) 2003-03-28 2004-03-26 Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisation et procede de traitement dermatologique
EP04742373A EP1620185A2 (fr) 2003-03-28 2004-03-26 Composition cosmetique ou pharmaceutique comprenant des acides amides, utilisation, et procedes de traitement dermatologique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0303886A FR2852841B1 (fr) 2003-03-28 2003-03-28 Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement

Publications (2)

Publication Number Publication Date
FR2852841A1 FR2852841A1 (fr) 2004-10-01
FR2852841B1 true FR2852841B1 (fr) 2006-08-04

Family

ID=32947268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0303886A Expired - Fee Related FR2852841B1 (fr) 2003-03-28 2003-03-28 Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement

Country Status (3)

Country Link
EP (1) EP1620185A2 (fr)
FR (1) FR2852841B1 (fr)
WO (1) WO2004087091A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2887773B1 (fr) * 2005-07-01 2008-05-30 Soc Extraction Principes Actif Utilisation d'un acide amine en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau.
CA2678990A1 (fr) 2007-02-22 2008-08-28 Ajinomoto Co., Inc. Procede de purification de 4-hydroxy-isoleucine
CN104027266A (zh) * 2014-05-26 2014-09-10 邓林生 高效生发乳液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695317B1 (fr) * 1992-09-07 1995-03-10 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
IL108583A (en) * 1994-02-07 1997-06-10 Yissum Res Dev Co Galactomannan emulsions and comestible products containing the same

Also Published As

Publication number Publication date
EP1620185A2 (fr) 2006-02-01
FR2852841A1 (fr) 2004-10-01
WO2004087091A2 (fr) 2004-10-14
WO2004087091A3 (fr) 2004-11-11

Similar Documents

Publication Publication Date Title
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
TR200500221T2 (tr) Farmasötik Maddeler Olarak Bisiklik Amino Asitler
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
EP1565482A4 (fr) Adn et proteines 3 de type a34 et a33, anticorps associes et methodes de traitement associees
DE602004021573D1 (de) Hydroxamate als therapeutische mittel
ATE380809T1 (de) Trisubstituiertes aryl- und heteroarylderivate als stoffwechselmodulatoren und die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
NO20075322L (no) NPY antagonister, samt femstilling og anvendelse av samme
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
NO20053855L (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
ATE301995T1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
BRPI0410316A (pt) composto, composição farmacêutica, uso dos compostos, e, método de tratamento de distúrbios mediados por vr1 e para o tratamento de distúrbios de dores
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
ATE486634T1 (de) Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
FR2852841B1 (fr) Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement
ATE325894T1 (de) Verfahren und rechnerprogrammprodukte zur erfassung der biologischen wirkung und/oder aktivität von arzneimitteln, chemischen substanzen und/oder pharmazeuitschen verbindungen auf der basis ihrer effekte auf den methylierungszustand der dna
FR2842422B1 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20111130